| mRNA |
SL 0101-1 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.005 |
| mRNA |
Cyclopamine |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.005 |
| mRNA |
KU-55933 |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.006 |
| mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
0.09 |
0.006 |
| mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.007 |
| mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.007 |
| mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.007 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.008 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.008 |